Please use a PC Browser to access Register-Tadawul
Moderna shares fall after FDA refuses to review new flu vaccine
Moderna -1.55%
Robinhood Markets, Inc. Class A -3.59%
Moderna MRNA | 52.56 | -1.55% |
Robinhood Markets, Inc. Class A HOOD | 73.39 | -3.59% |
MILAN, Feb 11 (Reuters) - Moderna MRNA.O shares opened 14% lower in Frankfurt on Wednesday in low volume after the U.S. Food and Drug Administration refused to review the company's approval application for its influenza vaccine.
The company's shares, which closed up 0.1% on Tuesday, are up 42% so far this year.


